Has Nishant Verma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $231,877 in general payments to Nishant Verma, MD across 440 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nishant Verma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nishant Verma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nishant Verma, MD

Clinical Cardiac Electrophysiology · Chicago, ILNPI 1013162817

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 41.2% of the total. 2025 is the largest year on record at $99,373, more than ten times the $9,777 reported in 2019. Among clinical cardiac electrophysiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$231,877in general payments, 2019–2025

Across 440 payments — averaging $526.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$95K
Abbott$32K
Medical Device Business Services, Inc.$27K
Biosense Webster, Inc.$24K
Medtronic$23K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$17K
plus $12K from 7 others

$49,073in research payments, 2019–2025

Across 19 payments — averaging $2582.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Janssen Research & Development, LLC$49K

What the payments were for

Consulting fees$50,37022%
Speaking & faculty fees$134,86558%
Grants$10,0004%
Travel & lodging$24,48311%
Food & beverage$12,0765%
Education$830%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	135	$95,423
Abbott	127	$32,349
Medical Device Business Services, Inc.	29	$27,246
Biosense Webster, Inc.	41	$24,387
Medtronic(2 entities)	57	$23,271
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	11	$17,000
Biotronik Inc.	29	$5,351
Baylis Medical Company Inc	2	$4,153
Altathera Pharmaceuticals LLC	2	$2,600
Cvrx, Inc.	1	$29
Impulse Dynamics (USA) Inc.	4	$25
Inspire Medical Systems, Inc.	1	$22
Cardiva Medical, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Farapulse$52,068
Carto 3$49,747
VersaCross Access Solution$17,208
LifeVest$17,000
ENSITE PRECISION$13,485
ENSITE$9,923
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,875
Sotalol Hydrochloride$2,600
AVEIR$2,296
ARCTIC FRONT ADVANCE$2,000
Arctic Front$1,500
Cardiac Mapping System$769
GENERAL - THERAPIES$595
PulseSelect$209
AFFERA MAPPING SYSTEM$191
EMBLEM MRI S-ICD$188
Micra$165
RELIANCE 4 FRONT$150
TACTICATH ABLATION CATHETER, SENSOR ENABLED$134
Ensite Cardiac Mapping System$133

How this compares

$231,877 in reported general payments places this provider in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois →

Medicare billing

Part B allowed, 2024

$358,344

Medicare patients

2,063

Services billed

5,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	343	$489,507
XareltoRivaroxaban	127	$181,557
MultaqDronedarone Hcl	22	$39,526
Dofetilide	30	$12,299
Flecainide Acetate	153	$6,536
Metoprolol Succinate	288	$5,264
Amiodarone Hcl	86	$1,940
SotalolSotalol Hcl	36	$909
Metoprolol Tartrate	66	$835
Diltiazem 24hr Er (Cd)Diltiazem Hcl	31	$544
Digoxin	13	$524
Diltiazem Hcl	15	$503
Warfarin Sodium	17	$340
Bisoprolol Fumarate	12	$225
ClopidogrelClopidogrel Bisulfate	11	$179

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Chicago

Roderick TungChicago$795K
Bradley KnightChicago$661K
Gaurav UpadhyayChicago$593K
Hany DemoChicago$297K
Susan KimChicago$186K
Martin BurkeChicago$183K
Arjun MehtaChicago$152K
Rod PassmanChicago$92K
Zaid AzizChicago$74K
Lalit WadhwaniChicago$73K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →